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Abstract
Rhesus monkey rhadinovirus (RRV) is a gamma-2 herpesvirus closely related to human herpesvirus 8 (HHV8). RRV encodes
viral FLICE inhibitory protein (vFLIP), which has death effector domains. Little is known about RRV vFLIP. This study intended
to examine its function in apoptosis. Here we found that RRV vFLIP inhibits apoptosis induced by tumor necrosis factor-
a (TNF-a) and cycloheximide. In HeLa cells with vFLIP expression, the cleavage of poly [ADP-ribose] polymerase 1 (PARP-1)
and activities of caspase 3, 7, and 9 were much lower than those in controls. Cell viability of HeLa cells with vFLIP expression
was significantly higher than control cells after apoptosis induction. However, RRV vFLIP appears unable to induce NF-kB
signaling when tested in NF-kB reporter assay. RRV vFLIP was able to enhance cell survival under starved conditions or
apoptosis induction. At early time points after apoptosis induction, autophagosome formation was enhanced and LC3-II
level was elevated in cells with vFLIP and, when autophagy was blocked with chemical inhibitors, these cells underwent
apoptosis. Moreover, RRV latent infection of BJAB B-lymphoblastoid cells protects the cells against apoptosis by enhancing
autophagy to maintain cell survival. Knockdown of vFLIP expression in the RRV-infected BJAB cells with siRNA abolished the
protection against apoptosis. These results indicate that vFLIP protects cells against apoptosis by enhancing
autophagosome formation to extend cell survival. The finding of vFLIP’s inhibition of apoptosis via the autophagy
pathway provides insights of vFLIP in RRV pathogenesis.
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Introduction
Rhesus monkey rhadinovirus (RRV) was first found in 1997 in
the New England Primate Research Center [1]. It was shown that
RRV has close sequence relatedness to Kaposi’s sarcoma-
associated herpesvirus (KSHV), a gamma herpesvirus that is
associated with Kaposi’s sarcoma, primary effusion lymphoma
(PEL) or body cavity based lymphoma (BCBL), and multicentric
Castleman’s disease [2,3,4]. Two major hindrances for KSHV
study are the lack of a permissive lytic system for high yield of
infectious virions and an appropriate animal model for the
investigation of KSHV pathogenesis [5]. Full length sequences of
two different RRV strains were subsequently obtained at the New
England Primate Research Center for strain 26–95 [6] and the
Oregon Regional Primate Research Center for strain 17577 [6,7].
The long unique region of the RRV genome is about 130 kb and
high overall sequence similarity to KSHV was found in both
strains. The RRV genomic organization is collinear with KSHV,
with the exception of a few genes encoding homologues of
cytokines and interferon regulatory factors. RRV can efficiently
replicate without any chemical induction in permissive cell lines
like rhesus macaque skin fibroblast cell line (RhF) [8].
High prevalence of antibodies to RRV was found in rhesus
monkey colonies at multiple facilities for at least ten years [1,9,10].
Experimental infection of rhesus monkeys with RRV led to
persistent antibody response and virus detection in lymph nodes,
oral mucosa, skin, and peripheral blood mononuclear cells
[11,12]. Co-inoculation of rhesus monkeys with RRV and simian
immunodeficiency virus (SIV) resulted in lymphoid hyperplasia
comparable to KSHV-associated multicentric Castleman’s disease
and has been explored as an animal model for KSHV [12,13].
Like other herpesviruses, RRV maintains two phases of
replication during infection, lytic and latent. RRV ORF71
encodes viral FLICE (FADD-like interleukin-1-converting en-
zyme)-inhibitory protein (vFLIP), which is expressed during latent
phase. The structure of this protein is homologous to cellular
FLIP, which contains two death effector domains resembling the
amino terminus of caspase 8 [6]. The interaction between death
effector domains of FLIP and adaptor protein Fas-associated
protein with death domain (FADD) can protect cells against
apoptosis. In the apoptosis pathway, members of the caspase
family of cysteine proteases are key mediators to initiate and
execute the apoptotic program [14,15]. Several caspases (caspase-
8, -9, and -10) play upstream ‘‘initiator’’ roles in the process of
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caspases. The activation of the initiator caspases can be induced by
external stimuli from the cell surface in the extrinsic apoptosis
pathway or signals originating from inside the cell in the intrinsic
apoptosis pathway.
Inhibition of apoptosis is generally observed for vFLIPs of
several viruses, such as Herpesvirus Saimiri (HVS), Molluscum
Contagiosum virus (MCV), and Sindbis virus (SV) [16,17,18].
Besides inhibition of apoptosis, KSHV vFLIP can constitutively
activate nuclear factor-kB (NF-kB) pathway through enhancing
the degradation of IkB, which allows the RelA/p65 subunit of NF-
kB to translocate into the nucleus and promote expression of
cellular genes [19]. KSHV vFLIP has also been shown to inhibit
autophagy induced by rapamycin, an immunosuppressant and
anti-cancer drug [20]. Autophagy is a catabolic process involving
the degradation of cytosolic components through the lysosomal
machinery.
RRV vFLIP has 174 aa with an expected molecular mass of
20 kDa [6,7]. There are approximately 40% similarity between
KSHV vFLIP and RRV vFLIP at nucleotide level, and 33%
identity at amino acid level. But little is known about RRV vFLIP.
Here we found that RRV vFLIP inhibits apoptosis and enhances
cell survival via enhancing autophagosome formation. The
enhancement of cell survival was observed in BJAB B-lympho-
blastoid cells latently infected with RRV when the cells were
induced to undergo apoptosis. Suppression of vFLIP expression in
the RRV-infected BJAB cells with siRNA abolished the protective
effect against apoptosis. Our findings provide a novel aspect of
vFLIP to inhibit apoptosis by employing autophagosome forma-
tion.
Results
Cloning and Expression of RRV ORF71 Gene
RRV ORF71 was cloned into a VenusN1 vector for expression
of vFLIP-Venus fusion protein. HEK293 cells were transfected
with either VenusN1-vFLIP or empty vector. The vFLIP-Venus
fusion protein was detected by a mouse monoclonal antibody
against GFP and the size of the fusion protein was approximately
48 kDa, while cells transfected with the empty vector yielded
a band at 27 kDa (Fig. 1A), as expected. Western blot analysis of
the cell lysates with rabbit anti-vFLIP antibody detected the
48 kDa fusion protein, while no signal was visible in whole
proteins from cells transfected with empty vector (Fig. 1B),
demonstrating the specificity of the antibody against vFLIP. These
results confirmed the expression of vFLIP fusion protein in the
cells transiently transfected. Similarly, the vFLIP fusion protein
was detected in HeLa cells transfected with VenusN1-vFLIP
(Fig. 1C). The results indicate that vFLIP expression is not cell
type-dependent.
Inhibition of the Apoptosis Signaling Pathway
Since RRV vFLIP contains two death effector domains, we
tested its effect on the apoptosis pathway. HeLa and HeLa-vFLIP
stable cells were induced to undergo apoptosis with TNF-a and
cycloheximide, and were harvested at 0, 6, 9, and 12 h after the
treatment. Cleavage of poly(ADP-ribose) polymerase-1 (PARP-1)
was assessed. PARP-1 is a nuclear DNA-binding zinc finger
protein that is involved in DNA repair [21]. PARP-1 proteolytic
cleavage is considered a classic hallmark for apoptosis. The PARP-
1 cleavage band at 89 kDa was observed in lysate from control
HeLa cells at 6, 9 and 12 h after apoptosis induction, while
undetectable in cells expressing vFLIP (Fig. 2A). The results
indicate that vFLIP inhibits apoptosis.
Apoptosis induction also leads to cleavage of inactive procas-
pases to form active caspases. Caspase 8 and 9 represent initiation
factors in the extrinsic and intrinsic pathways, respectively, and
induce the cleavage of caspase 3 and 7, the executive factors in the
apoptosis pathway. To further confirm the effect of vFLIP on
apoptosis signaling, we conducted caspase activity assays 6 h after
apoptosis induction. Caspase activities of caspase 3/7, 8, and 9 in
vFLIP-positive cells were 55%, 13%, and 58%, respectively, lower
than those in control HeLa cells (Fig. 2B). The reduction of
caspase activities of caspase 3, 7, and 9 in HeLa-vFLIP cells may
account for the reduced cleavage of PARP-1.
Reactive oxygen intermediates play a critical role in apoptosis
induced by TNF-a and cycloheximide, and overexpression of
manganese superoxide dismutase (MnSOD) has been previously
shown to prevent apoptosis [22,23]. Superoxide dismutases (SOD)
are a class of enzymes that catalyze the dismutation of superoxide
into oxygen and hydrogen peroxide [24]. Three forms of
superoxide dismutase are present: SOD1 is located in the
cytoplasm, SOD2 in the mitochondria, and SOD3 is extracellular.
SOD2 contains manganese in its reactive centre and is also known
as MnSOD. The transcript of MnSOD in the HeLa cells was
assessed by real time RT-PCR 4 h after apoptosis induction.
MnSOD expression was significantly up-regulated to almost 90
folds in HeLa-vFLIP stable cells as compared with control
(Fig. 2C). The MnSOD elevation was consistent with the
reduction of caspase activity in vFLIP-stable cells.
The upregulation of MnSOD is not due to activation by NF-kB
signaling, as vFLIP is unable to activate NF-kB, shown by NF-kB
luciferase reporter assay (Fig. 2D). HeLa cells were transfected
with a NF-kB reporter plasmid pGL4.32[LUC2P/NF-kB-RE/
HYGRO] and VenusN1-vFLIP. VenusC1-vFLIP and an empty
vector were also included in the test. TNF-a was included as
a positive control to activate NF-kB signaling. The luciferase
reporter assay showed that luminescence signal in cells with vFLIP
expression was low and similar to cells that were transfected with
empty vector, whereas TNF-a treatment of HeLa cells induced 12-
fold increase (Fig. 2D). TNF-a treatment of HeLa cells transfected
with VenusN1-vFLIP induced 9-fold elevation, which was
significantly higher than the cells without treatment. Transfection
of HeLa cells with prokaryotic vector pGEX-3X did not affect the
NF-kB activation after TNF-a induction. This result indicates that
vFLIP is unable to activate NF-kB signaling.
To verify the finding in the NF-kB luciferase reporter assay,
subcellular fractionation of HeLa cells was conducted to determine
NF-kB subcellular location. After NF-kB is activated by TNF-a,i t
translocates into the nucleus and activates expression of a myriad
of genes. HeLa and HeLa-vFLIP stable cells were either untreated
or treated with TNF-a. The addition of TNF-a and cycloheximide
Figure 1. Expression of RRV vFLIP protein is detected by
Western blotting. The cells were transfected with VenusN1-vFLIP or
empty vector (EV). Lysate of mock-transfected cells was included as
a control. A. Detection of vFLIP-Venus fusion protein in HEK293 cells by
mouse anti-GFP antibody. Molecular weight markers are indicated on
the left of the images. B. Detection of vFLIP-Venus fusion protein in
HEK293 cells by rabbit anti-vFLIP antibody. C. Detection of vFLIP-Venus
fusion protein in HeLa cells by rabbit anti-vFLIP antibody.
doi:10.1371/journal.pone.0039438.g001
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PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e39438Figure 2. RRV vFLIP inhibits apoptosis in HeLa cells. A. Reduction of PARP-1 cleavage in HeLa cells detected by Western blotting. HeLa and
HeLa-vFLIP stable cells were treated with tumor necrosis factor-a (TNF-a) and cycloheximide to induce apoptosis, and harvested at 0, 6, 9, and 12 h
after the treatment. PARP-1 cleavage was detected as a marker of apoptosis. Tubulin was detected on the same membrane for loading normalization.
B. Reduction of activities of caspase 3/7, 8, and 9. HeLa-vFLIP stable cells and HeLa cells were treated with TNF-a and cycloheximide for 6 h. Relative
percentages of caspase activities in comparison with normal HeLa cells are shown. Significant differences between HeLa-vFLIP and HeLa cells are
denoted by ‘‘**’’, which indicates P,0.01. C. Up-regulation of transcript of MnSOD in HeLa-vFLIP stable cells after apoptosis induction detected by
real-time PCR. Relative fold in comparison with control HeLa cells under the same treatment is shown. D. RRV vFLIP is unable to activate the NF-kB
luciferase reporter. HeLa cells were transfected with NF-kB reporter plasmid pGL4.32[LUC2P/NF-kB-RE/HYGRO], VenusN1-vFLIP (vF1), VenusC1-vFLIP
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4 h after the induction and fractions of the nucleus and cytoplasm
were separated. Western blot analysis with antibody against the
NF-kB p65 subunit showed that p65 remained in the cytoplasm in
cells with stable vFLIP expression, while addition of TNF-a or
a combination of TNF-a and cycloheximide led to p65 nuclear
translocation (Fig. 2E). The result suggests that vFLIP is unable to
cause nuclear translocation of NF-kB. Detection of b-tubulin and
PARP-1 in only the cytoplasmic and the nuclear fractions,
respectively, demonstrated the successful separation of the two
fractions.
The data above showed that RRV vFLIP inhibited the signaling
cascade of the apoptosis pathway. To test whether the anti-
apoptotic function of vFLIP was sufficient to protect the cells from
apoptotic death, we conducted a cell viability assay of the HeLa-
vFLIP stable cells at 0 and 38 h after apoptosis induction with
TNF-a and cycloheximide. Compared with normal HeLa cells at
0 h, relative cell viability of HeLa-vFLIP stable cells at 38 h after
apoptosis induction was 0.85-fold, while that of the control cells
was 0.43-fold, similar to 0.39-fold of un-transfected HeLa cells
(Fig. 2F). This result indicated that vFLIP expression protected the
cells from apoptotic cell death.
vFLIP Enhances Cell Survival under Starved Condition
Enhanced cell survival is one of the features of tumor cells. To
determine whether RRV vFLIP can enhance cell survival under
starved condition, we replaced cell culture medium of HeLa,
HeLa-vFLIP, and HeLa-VenusN1 cells with Hank’s balanced salt
solution (HBSS). These cells were observed at 0, 24, and 48 h after
HBSS addition and images were taken under bright field
microscopy. HeLa-vFLIP stable cells survived longer than the
other cells under starved condition (Fig. 3A). Cell viability of
vFLIP-stable cells was 1.24- and 1.58-fold higher than control
HeLa cells at 24 and 48 h, respectively, after HBSS addition
(Fig. 3B). The cells with empty vector had slightly lower viability
levels than control HeLa cells. The result indicated that RRV
vFLIP might be involved in autophagy to extend cell survival,
since autophagy is a cell survival mechanism to turn over damaged
organelles and long-lived proteins in the cytoplasm during
starvation.
vFLIP Enhances Autophagosome Formation in Cells
Undergoing Apoptosis Induction
Autophagy is a dynamic and multi-step process and LC3-II has
been widely used as a marker [25,26]. Microtubule-associated
protein 1A/1B-light chain 3 (LC3) is a soluble protein with
a ubiquitous distribution in mammalian cells. During autophagy,
the cytosolic form of LC3 (LC3-I) is cleaved at its C-terminus and
conjugated to phosphatidylethanolamine to form LC3-phosphati-
dylethanolamine conjugate (LC3-II), which is incorporated into
autophagosomal membranes. Thus detecting changes in LC3
lipidation and localization has become a reliable method for
monitoring autophagy [27]. HeLa cells were co-transfected with
VenusN1-vFLIP plasmid and mCherry-LC3 and, the next day,
were induced to undergo apoptosis with TNF-a and cyclohexi-
mide. The mCherry-LC3 was used because mCherry is stable in
lower pH than CFP and is easier to observe even when
autophagosomes are fused with lysosomes [28]. The cells were
observed for autophagosome formation 3 h after apoptosis
induction. The HeLa cells with vFLIP expression had more
punctated autophagosomes after apoptosis induction than cells
with empty vector (Fig. 4A). The HeLa cells with vFLIP expression
also had visible punctated autophagosomes before apoptosis
induction. For Western blot detection of LC3-II in the cells,
HeLa-vFLIP stable and HeLa-empty vector cells were transfected
with CFP-LC3 plasmid and, the next day, were induced to
undergo apoptosis. The cells were harvested for western blotting at
0, 4, and 6 h after apoptosis induction. Densitometry analysis
showed that LC3-II in HeLa-vFLIP stable cells at 0, 4, and 6 h
after apoptosis induction were 1.6-, 1.7- and 1.5-fold higher than
that in HeLa-empty vector cells at 0 h (Fig. 4B). At 4 and 6 h after
apoptosis induction, the LC3-II in HeLa-empty vector cells
increased to 1.2-fold higher than 0 h.
To determine whether autophagy plays a role in vFLIP’s
inhibition of apoptosis, two experiments were performed to inhibit
autophagy pathway at two critical steps; autophagosome forma-
tion and degradation of autophagosomes in lysosomes. HeLa-
vFLIP stable cells were treated with 3-MA for one hour before
apoptotic induction to inhibit autophagosome formation. The cells
were harvested at 10 h after apoptotic induction for Western
blotting. The band of cleaved PARP-1 at 89 kDa was observed in
the cells treated with 3-MA, but could not be seen in the mock-
treated control (Fig. 4C). The result indicated that after 3-MA
treatment of the cells, vFLIP could no longer protect the cells from
apoptosis induction. This suggested that autophagosome forma-
tion was needed for the anti-apoptotic function of RRV vFLIP,
which was consistent with the observation of a significant increase
of punctated autophagosomes after apoptosis induction.
Further testing was conducted to determine whether final
degradation of autophagic cargo inside autophagolysosomes had
any effect on vFLIP’s inhibition of apoptosis. HeLa-vFLIP stable
cells were treated with ammonium chloride at 4, 6, and 8 h after
apoptosis induction to prevent acidification in lysosomes and
harvested for Western blot analysis. In HeLa-vFLIP stable cells,
the band of cleaved PARP-1 at 89 kDa was observed at 4 and 6 h,
and became weaker at 8 h, while in HeLa cells with empty vector,
a strong band of PARP-1 at 89 kDa was observed at all three time
points (Fig. 4D). This result indicated that inhibition of
autophagolysosomes at 4 and 6 h after apoptosis induction had
an inhibitory effect on vFLIP’s anti-apoptotic function.
Latent RRV Infection of BJAB Cells Protects the Cells
Against Apoptosis via Autophagy, and Suppression of
vFLIP Expression Abolishes the Protection
Although several cell lines can be infected with RRV, the
main target cells of RRV latent infection in vivo are B cells [9].
(vF2), empty vector VenusN1 (EV1), or VenusC1 (EV2). TNF-a was used to activate NF-kB as a positive control. Prokaryotic expression vector pGEX-3X
was included as a control. Luciferase signals were measured 4 h after TNF-a addition. Relative folds in comparison with EV1 control are shown.
Significant differences between cells with vF1 in the presence or absence of TNF-a induction are denoted by ‘‘**’’. E. RRV vFLIP is unable to induce
nuclear translocation of NF-kB subunit p65. HeLa cells (top panel image) and HeLa-vFLIP stable cells (lower panel image) were treated with TNF-a or
combination of TNF-a and cycloheximide for 4 h and harvested for fractionation of cytoplasmic and nuclear portions, followed by Western blotting
with p65 antibody. Tubulin and PARP-1 were detected on the same membrane to confirm the separation of cytoplasmic and nuclear fractions. F.
Extension of cell viability after apoptosis induction. HeLa, HeLa-empty vector (EV) and HeLa-vFLIP cells were tested by CellTiter-Glo Cell Viability Assay
at 0 and 38 h after apoptosis induction. Relative folds in comparison with normal HeLa cells at 0 h are shown. Significant differences between HeLa-
vFLIP and HeLa-EV cells are denoted by ‘‘**’’.
doi:10.1371/journal.pone.0039438.g002
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cells since vFLIP is a latent protein that could play a role during
the latent phase of RRV infection. BJAB cells were infected with
RRV at a multiplicity of infection (MOI) of 2 TCID50 per cell
and were maintained for two weeks in culture. BJAB cells latently
infected with RRV (BJAB-RRV) and normal BJAB cells were
induced to undergo apoptosis and were harvested for Western
blot analysis at 2 h after the treatment. The cleaved band of
PARP-1 at 89 kDa was strong in BJAB, but much weaker in
BJAB-RRV cells (lane 2 in both images of Fig. 5A). The ratio of
top band to low band of PARP-1 for BJAB-RRV cells was 4,
while 1.1 for BJAB cells. To test whether autophagy was needed
for the inhibition of apoptosis in BJAB-RRV, cells were treated
with 3-MA for 3 hours prior to apoptosis induction, or
ammonium chloride at the same time as apoptosis induction.
PARP-1 cleavage was highly increased in BJAB-RRV when
Figure 3. RRV vFLIP enhances survival of HeLa cells under starved condition. A. Bright-field micrographs showing the cells under starvation
at 0, 24 and 48 h. Normal HeLa, HeLa-vFLIP stable cells and HeLa-empty vector (EV) cells were starved after culture medium was replaced with Hank’s
balanced salt solution (HBSS). B. Cell viability assay of HeLa cells after starvation. The cells were assayed 24 and 48 h after starvation by CellTiter-Glo
Cell Viability Assay. Relative folds are shown in comparison with normal HeLa cells at 24, and 48 h, respectively, after normalization of cells at 0 h.
Significant differences between HeLa-vFLIP and HeLa-EV cells are denoted by ‘‘*’’ and ‘‘**’’, which indicate P,0.05 and P,0.01, respectively.
doi:10.1371/journal.pone.0039438.g003
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the second image of Fig. 5A). The ratio of top band to low band
of PARP-1 in BJAB-RRV when treated with ammonium
chloride or 3-MA was reduced to 0.75 and 0.44, respectively.
These treatments also increased PARP-1 cleavage in normal
BJAB cells (lane 3 and 4 in the first image of Fig. 5A), as
expected. This result indicated that the anti-apoptotic function
coupled with autophagosome formation in RRV-infected BJAB
cells corroborated with the data from HeLa cells stably
expressing vFLIP. The vFLIP protein was detected in RRV-
infected BJAB cells (Fig. 5B). The cell viability assay showed that
viability of BJAB-RRV cells at 3 h after apoptosis induction was
0.79-fold of the cells at 0 h, while viability of BJAB cells 3 h after
apoptosis induction was 0.29-fold of the cells at 0 h (Fig. 5C).
The result indicated that RRV infection significantly extended
the survival of BJAB cells after apoptosis induction, which was
consistent with the results of PARP-1 cleavage.
To further confirm that the inhibition of apoptosis via the
autophagy pathway in RRV-infected BJAB cells was due to vFLIP
expression, BJAB-RRV cells were treated with a siRNA against
vFLIP to knockdown vFLIP expression in the cells. An irrelevant
siRNA was included as a control. To test if the siRNA against
vFLIP could knockdown vFLIP expression in BJAB-RRV cells,
real-time RT-PCR was conducted. The results showed that the
treatment of BJAB-RRV cells with siRNA against vFLIP reduced
vFLIP mRNA to 10% in comparison with mock-treated control,
while vFLIP mRNA level in cells with control siRNA had no
significant difference from mock-treated control (Fig. 5D). The
result indicated that the siRNA to vFLIP effectively suppressed the
vFLIP expression in BJAB cells latently infected by RRV.
The BJAB-RRV cells were induced to undergo apoptosis the
next day after siRNA transfection. Western blot analysis showed
that PARP-1 cleavage was increased in BJAB-RRV cells after
treatment with vFLIP siRNA in comparison with the control
Figure 4. RRV vFLIP enhances autophagosome formation after apoptosis induction. A. RRV vFLIP expression leads to more punctated
autophagosomes in HeLa cells after apoptosis induction. HeLa cells were co-transfected with mCherry-LC3 and VenusN1-vFLIP or empty vector (EV),
and induced with TNF-a and cycloheximide for 3 h the next day. The cells were observed under confocal fluorescence microscopy. Nuclear DNA was
counterstained with DAPI. Mock: no apoptosis induction. TNF: 3 h after addition of TNF-a and cycloheximide. B. Elevation of LC3-II level in cells with
vFLIP expression after apoptosis induction. HeLa-vFLIP stable and HeLa cells with EV were transfected with CFP-LC3, and induced with TNF-a and
cycloheximide to undergo apoptosis the next day. The cells were harvested 0, 4, and 6 h after the induction for Western blotting of LC3. Tubulin was
blotted for normalization. The relative ratios of LC3-II (the lower band of LC3 image) in comparison with HeLa-EV cells 0 h after apoptosis induction
are shown below the image. C. RRV vFLIP is unable to inhibit apoptosis when cells are treated with 3-MA. Addition of 3-MA to HeLa-vFLIP stable cells
was done 1 h before addition of TNF-a and cycloheximide. The cells were harvested 10 h after TNF-a addition for Western blotting of PARP-1
cleavage. D. Treatment with NH4Cl reduces vFLIP’s capability to inhibit apoptosis. NH4Cl was added to HeLa-vFLIP or HeLa-EV cells at 4, 6, and 8 h
after apoptosis induction. The cells without apoptosis induction were included as control.
doi:10.1371/journal.pone.0039438.g004
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PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e39438Figure 5. RRV latent infection of BJAB cells protects the cells from apoptosis. A. RRV latent infection of BJAB cells protects the cells against
apoptosis and inhibition of autophagy abolishes the protective effect. BJAB cells latently infected with RRV (BJAB-RRV) were either untreated, treated
with 3-MA for 3 h prior apoptosis induction by TNF-a and cycloheximide, or treated with ammonium chloride at the same time of the apoptosis
induction. The cells were harvested 2 h post-apoptosis induction for Western blotting of PARP-1 cleavage. Similar treatment of uninfected BJAB cells
was included as a control. The ratio of top PARP-1 band to low band is shown under the image. B. Detection of vFLIP in RRV-infected BJAB cells by
Western blotting with rabbit anti-vFLIP antibody. C. Cell viability assay of BJAB and BJAB-RRV cells 3 h after apoptosis induction. Relative folds in
comparison with uninfected BJAB cells at 0 h are shown. Significant differences between BJAB and BJAB-RRV cells after apoptosis induction are
denoted by ‘‘**’’, which indicates P,0.01. D. Suppression vFLIP expression in RRV-infected BJAB cells by siRNA. BJAB cells latently infected with RRV
were transfected with a siRNA against vFLIP. An irrelevant siRNA was included as a control. Real-time RT-PCR was conducted to assess vFLIP transcript
level. Relative percentages in comparison with mock-treated control are shown. Significant differences between siRNA-treated and mock-treated
BJAB-RRV cells are denoted by ‘‘**’’. E. Suppression of RRV vFLIP gene expression in BJAB-RRV cells leads to loss of the capability against apoptosis.
BJAB cells latently infected with RRV were transfected with siRNA against vFLIP 15 h before apoptosis induction. Treatment of uninfected BJAB cells
was included as a control. The cells were harvested 2 h after treatment with TNF-a and cycloheximide for Western blotting of PARP-1 cleavage. The
ratios of top PARP-1 band to low band are shown under the image.
doi:10.1371/journal.pone.0039438.g005
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band of PARP-1 in BJAB-RRV cells when treated with vFLIP
siRNA was reduced to 0.54, while 2.53 for the cells with control
siRNA. The result indicated that vFLIP was needed for apoptosis
inhibition. Treatment of normal BJAB cells with both siRNAs led
to a slight increase in PARP-1 cleavage after apoptosis induction.
The siRNA treatment of the BJAB cells without apoptosis
induction had no effect on PARP-1 level. This result suggested
that vFLIP could inhibit apoptosis via the autophagy pathway in
RRV-infected cells.
Discussion
Several c-herpesviruses contain vFLIP genes. However, not all
of the vFLIPs have similar functions. In this study, we found RRV
vFLIP is able to inhibit apoptosis via enhancing autophagosome
formation. Unlike KSHV vFLIP, RRV vFLIP cannot activate NF-
kB. A unique motif, PYQLT, was found in the second death
effector domain of KSHV vFLIP, and has the function of NF-kB
activation by directly binding to TNF receptor associated factor 2
(TRAF2) [29]. But the TRAF-interacting motif is not available in
RRV vFLIP, which may be the reason for failing to activate NF-
kB pathway.
A combination of TNF-a and cycloheximide was used to induce
apoptosis as either one of them was unable to induce apoptosis at
the concentrations used in this work. The cycloheximide sensitizes
the cells to undergo apoptosis induced by TNF-a [30,31]. The
activation of caspase 9 indicates that the intrinsic pathway was
activated by the apoptosis induction. We speculate that the
activation of the intrinsic pathway might be due to the
combination of the two compounds in inducing cross talk from
extrinsic pathway or the detection time after the induction. The
second point is less likely as we tested caspase activity in several
time points after the induction and a similar trend was observed.
Our finding of up-regulation of MnSOD in HeLa-vFLIP stable
cells is consistent with the activation of the intrinsic pathway.
MnSOD contributes to suppression of apoptosis through reducing
accumulation of intracellular superoxide to enhance cell survival
[32].
MnSOD gene expression in HeLa cells with RRV vFLIP
expression was elevated in the absence of NF-kB activation. This
finding suggests that the NF-kB pathway may not be the only
factor to control MnSOD expression, but other transcription
factors could also be involved in the regulation of this gene as well.
It was reported that p53 responds to physiological stress by
stimulating redox-controlling genes to reduce the ROS level [33].
The increase of the MnSOD transcript in HeLa cells with vFLIP
expression suggests that RRV vFLIP might employ other
transcription factors.
Expression of vFLIP in HeLa cells enhanced cell survival under
starved condition. Since nutrient deprivation induces autophagy
[34], extension of cell survival of HeLa-vFLIP cells indicates that
vFLIP suppresses autophagy. Autophagy is a multiple-step process
that begins with the formation of autophagosome-cytoplasmic
vesicles that have a double membrane and contain cytoplasmic
cargo, proceeds with fusion of autophagosomes with lysosomes to
become autophagolysosomes, and ends with degradation of the
contents in the autophagolysosomes. Enhancement of cell survival
under starved condition in HeLa-vFLIP stable cells prompted us to
determine autophagy before and after apoptosis induction.
Interestingly, we found that autophagosome formation was
increased in HeLa-vFLIP stable cells at early time points after
apoptosis induction. When autophagy was inhibited at either early
autophagosome formation by 3-MA or late autophagosome
degradation by ammonium chloride, vFLIP could no longer
protect the cells against apoptosis. The addition of ammonium
chloride at 8 h after apoptosis induction to inhibit autophagosome
degradation had less effect on the function of RRV vFLIP in
inhibition of apoptosis than earlier time points. The apoptosis
induction in HeLa cells is much more efficient in the presence of
ammonium chloride. Our result suggests that autophagy at early
time points after apoptosis induction is essential for RRV vFLIP to
protect the cells from apoptosis. Our data is consistent with
previous publications that explored both apoptosis and autophagy
pathways. For example, two colon-cancer-derived cell lines, colon
26 and HT29, significantly underwent apoptosis after the
combination treatment of 3-MA to inhibit autophagy and 5-FU
to induce apoptosis [35]. Likewise, MCF-7, a breast cancer cell
line, delayed apoptotic death following autophagy induction by
nutrient starvation [34]. Inhibition of the expression of Beclin 1
and Atg7 stimulates apoptosis in DNA-damaged MCF-7 cells.
LC3-II was present at a relatively higher level in cells with RRV
vFLIP expression than control cells even before apoptosis in-
duction (Fig. 4A&B). We speculate that RRV vFLIP induces
a basal level of autophagy to promptly respond to stress signals in
order to promote cell survival. The greater accumulation of
autophagosomes in HeLa-vFLIP stable cells is possibly due to
increased formation or slower turnover rate. The data in Fig. 4
indicates that greater autophagosome formation might account for
the increased level. Our data is consistent with previous
observations that autophagy delays apoptosis of cancer cells. It
has been reported that autophagy in MCF-7 cells due to nutrient
starvation delays apoptotic death induced by camptothecin,
a DNA-damaging compound [34]. Treatment with autopahgy
inhibitors increased mitochondrial depolarization and caspase-9
activity, resulting in apoptosis. RRV vFLIP promotes autophago-
some formation during early time points after apoptosis induction
to prevent apoptotic cell death.
Although autophagy is considered a mechanism to enhance cell
survival in adverse conditions, it is also classified as type II
programmed cell death due to accumulation of autophagosomes in
the cytoplasm under pathological conditions. It was reported that
FLIP inhibits autophagic cell death induced by rapamycin by
preventing Atg3 from binding and processing LC3 [20]. We found
that RRV vFLIP is also able to inhibit rapamycin-induced
autophagic cell death (unpublished observation), which is consis-
tent with other vFLIPs described in the previous report. However,
the enhancement of autophagosomes in HeLa-vFLIP stable cells
after apoptosis induction indicates that a different mechanism is
activated because vFLIP binding Atg3 inhibits autophagy. How
the RRV vFLIP activates other mechanisms while avoiding the
effect of interaction with Atg3 is not known. We speculate that
RRV vFLIP activates autophagy through interaction with
a cellular factor activated by apoptosis induction. The upregula-
tion of MnSOD in HeLa-vFLIP stable cells is consistent with this
speculation.
Since B lymphocytes are target cells in hosts in natural infection
of RRV, BJAB cells were latently infected with RRV to verify the
observation in HeLa cells with vFLIP expression. It has been
reported that RRV latently and persistently infected immortalized
B-cell lines [36]. The expression of the RRV vFLIP during latent
phase was verified by real-time RT-PCR and Western blotting.
Interestingly, BJAB cells with RRV latent infection resisted
apoptosis induction. Moreover, when autophagy was inhibited
with 3-MA or ammonium chloride, the BJAB cells with RRV
infection lose the ability to escape from apoptosis. Suppression of
vFLIP expression with siRNA leads to loss of the anti-apoptosis
effect in BJAB-RRV, which indicates that vFLIP is possibly the
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BJAB cells is consistent with the observation in HeLa cells. There
are other genes in RRV, such as vBcl-2, that inhibit autophagy
and apoptosis. Our data indicates that these other genes may not
be involved in the protection of cells from apoptosis induction via
the autophagy pathway.
The exact mechanism for RRV vFLIP to enhance autophago-
some formation during early apoptosis remains unclear. The
autophagy pathway is implied to contribute in cell survival by cross
talking with the apoptosis pathway. Mitochondria membrane
permeabilization and cytochrome C release are a critical step
during apoptotic cell death. However, when the damage in
mitochondria is below the threshold required for apoptosis, the
damaged mitochondria will be sequestered in autophagosomes.
The autophagic process provides a source of metabolic energy in
the form of ATP from damaged organelles and long-lived proteins.
The effects of RRV vFLIP to enhance autophagy in apoptosis
induction and inhibit rapamycin-induced autophagic cell death
provide a great benefit to promote cell survival and prevent cell
death. Further study on the interaction of RRV vFLIP with
cellular factors is warranted and may yield informative data that
can be extrapolated to assist the management of KSHV-associated
malignancies.
In summary, our data show that RRV vFLIP inhibits apoptosis
via the enhancement of the autophagy pathway to promote cell
survival, while autophagic cell death is avoided. BJAB cells with
RRV latent infection resists apoptosis induction and, when
autophagy is inhibited, the apoptosis resistance disappears.
Suppression of vFLIP expression in RRV-infected BJAB cells
with siRNA also leads to loss of the apoptosis resistance, indicating
that vFLIP-mediated activation of autophagy signaling protects
the cells from apoptosis.
Materials and Methods
Cells and Viruses
Cell lines HeLa and HEK293 were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum (FBS). Transfection of the cells was accomplished
with GeneExpresso 8000 (Lab Supply Mall, Gaithersburg, MD) as
per the manufacturer’s instructions. Cell line RhF was a gift from
B. Damania [8] and maintained in DMEM supplemented with
10% FBS. RRV26-95 was a gift from R.C. Desrosiers [36] and
was propagated in RhF cells. BJAB cells were maintained in
RPMI1640 medium supplemented with 10% FBS. Stable HeLa
cells expressing CFP-LC3 have been described previously [28] and
were maintained in DMEM supplemented with 10% FBS and
G418 (Invitrogen, Carlsbad, CA) at 400 mg/ml.
Plasmids
RRV ORF71 gene was amplified by PCR from RRV DNA
isolated from culture supernatant of RRV-infected RhF cells. PCR
was conducted with primers R71F2 and R71R3 (Table 1) that
contain restriction sites for EcoRI and BamHI, respectively, for
directional cloning into a VenusN1 vector, as described previously
[37]. PCR product with primers R71F2 and R71R2 was cloned
into a VenusC1 vector. In VenusN1, ORF71 was cloned upstream
of Venus; whereas in VenusC1, it was cloned downstream of
Venus to confirm the vFLIP expression pattern. This resulted in
two recombinant plasmids that expressed the vFLIP-Venus fusion
protein after transfection.
The ORF71 gene was also amplified with primers R71F1 and
R71R1 (Table 1) that contain restriction sites for BamHI and
EcoRI, respectively, and was cloned into pGEX-3X vector for
prokaryotic protein expression and purification of vFLIP.
Construction of a CFP-LC3 plasmid has been previously
described [25,26]. Construction of mCherry-LC3 plasmid has
been recently described [28].
Protein Purification and Antibody Production
RRV vFLIP was expressed in BL21 E. Coli cells as a fusion
protein of vFLIP-GST from a pGEX-3X-vFLIP plasmid with the
induction of 1 mM IPTG (Promega, Madison, WI). The vFLIP-
GST fusion protein was purified by B-PER GST Fusion Protein
Purification Kits (Fisher Scientific, Pittsburgh, PA) according to
the manufacturer’s instructions. Purified vFLIP-GST fusion pro-
tein was used to immunize rabbits for vFLIP antibody preparation
(GenScript Corporation, Piscataway, NJ). Rabbit anti-vFLIP
antibody was purified from the antiserum by affinity-purification
with a CarboxyLink
TM Kit (Fischer Scientific), which was used to
covalently link purified vFLIP-GST fusion protein to agarose
beads. The vFLIP antibody was verified by detection of vFLIP
expressed in HeLa cells in Western blot analysis.
Confocal Fluorescence Microscopy
Cells were seeded directly onto cell culture plates containing
coverglass, incubated overnight, and transfected the next day. At
24 h post transfection, the coverglass was observed directly under
confocal fluorescence microscopy or fixed with 1% paraformal-
dehyde and mounted onto a slide with anti-fade mounting solution
containing 4969-diamidino-2-phenylindole (DAPI) (Invitrogen)
before observation.
Western Blot Analysis
Cells were transfected with either vFLIP expression plasmid or
empty vector. At 24 h post-transfection, the cells were harvested
with Laemmli sample buffer. Western blot analysis was conducted
as previously described [38]. Briefly, the whole proteins in cell
lysates were resolved in 12% polyacrylamide gel. The separated
proteins were transferred to nitrocellulose membrane and probed
with rabbit anti-vFLIP antibody. Any specific reaction was
Table 1. Primers used for ORF71 cloning and qPCR.
Primer
a Sequence (59 to 39)




















aF, forward; R, reverse.
bRestriction sites of BamHI, XhoI and EcoRI included in the primers are italicized.
doi:10.1371/journal.pone.0039438.t001
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peroxidase (Sigma, St. Louis, MO) and revealed by the addition of
chemiluminescence substrate. Chemiluminescence signal was
collected by a ChemiDoc XRS imaging system (Bio-Rad
Laboratories, Hercules, CA). Beta-tubulin was detected on the
same blot membrane to normalize protein loading. Digital image
acquisition and densitometry analyses were conducted by using
Quantity One program (Version 4.6) (Bio-Rad). Similarly,
expression of other proteins was detected with corresponding
antibodies: GST (Rockland Immunochemicals Inc., Gilbertsville,
PA), GFP, b-tubulin (Sigma), LC3 (Cell Signaling Technology,
Danvers, MA), NF-kB p65, and PARP-1 (Santa Cruz Bio-
technology, Santa Cruz, CA).
Stable Expression of vFLIP in HeLa Cells
HeLa cells were transfected with VenusN1-vFLIP and the cells
containing the plasmid were selected in medium supplemented
with G418 (Invitrogen) at 400 mg/ml. Fluorescence-activated cell
sorting was conducted to enrich cells with GFP expression. Sorted
cells were plated and cultured to expand the cell population.
Sorting and expansion were repeated three times to enrich and
stabilize the cells with GFP expression. The expression of vFLIP
was confirmed with Western blot analysis using rabbit anti-vFLIP
antibody. The stable HeLa cells were stored in a liquid nitrogen
container and used in this study.
Apoptosis Induction
Tumor necrosis factor-a (TNF-a) (R&D Systems, Minneapolis,
MN) and cycloheximide (Sigma) were added to cells at final
concentrations of 50 ng/ml and 2.5 mg/ml, respectively, to induce
apoptosis. The cells were harvested at different time points after
apoptosis induction for RNA isolation or Western blot analysis, as
indicated. Either TNF-a or cycloheximide alone at their respective
concentrations used in this study cannot induce apoptosis. To
inhibit the autophagosome formation step in autophagy, cells were
treated with 3-methyladenine (3-MA) (Fisher) at a final concen-
tration of 10 mM for one hour before apoptosis induction. To
interrupt fusion and degradation of autophagosomes in lysosomes,
cells were treated with ammonium chloride (NH4Cl) (Fisher) at
a final concentration of 20 mM at 4, 6, and 8 h after apoptosis
induction. At 10 h after apoptosis induction, the cells were
harvested for Western blot analysis.
Cell Viability Assay and Caspase Activity Detection
Cell viability was determined with CellTiter-Glo Luminescent
Cell Viability Assay (Promega). Briefly, cells were cultured in a 96-
well plate and CellTiter-Glo reagent was added and incubated for
10 minutes at room temperature. The luminescence signal was
measured with a VICTOR
3 Multilabel Counter (Perkin-Elmer,
Waltham, MA). Relative percentages of luminescence intensity
were calculated by comparison to mock-treated controls.
Activities of caspase-3, -7, -8, and -9 were detected with
Caspase-Glo 3/7, Caspase-Glo 8, and Caspase-Glo 9 Assay kits
(Promega). Caspase-Glo reagent was added to the cells and
incubated for 30 minutes at room temperature. The luminescence
signal was measured and relative percentages of luminescence
intensity were calculated in comparison to controls.
For nutrient deprivation, the cells were seeded into 12-well
culture plate and incubated overnight at 37uC. On the next day,
the culture medium was replaced with Hank’s balanced salt
solution (HBSS). The cells were either observed under a micro-
scope or harvested for cell viability assay at 0, 24, and 48 h after
the HBSS addition.
Real-time PCR
Total RNA was isolated from cells lyzed in TRIzol reagent
(Invitrogen). For real-time PCR analysis, RNA was first treated
with RNase-free DNase (Promega) to remove carryover DNA
from the RNA isolation procedure. Reverse transcription was
carried out using AMV (avian myeloblastosis virus) reverse
transcriptase and random hexamers (Promega). Real-time PCR
primers that were used in this study were listed in Table 1. Real-
time PCR with SYBR Green detection (Bio-Rad) was performed
as previously described [39]. The actin transcript was also
amplified from the same samples as an internal control for
normalization. The gene expression levels in vFLIP-expressing
cells were quantified via the 2
2DDCT method in comparison with
a vFLIP-negative control [40].
NF-kB Reporter Assay
HeLa cells were co-transfected with a pGL4.32[luc2P/NF-kB-
RE/Hygro] Vector (Promega) containing a NF-kB response
element and either VenusN1-vFLIP or VenusN1 empty vector.
VenusC1-vFLIP and empty VenusC1 vector were also used in this
assay. Plasmid pRL-TK (Promega) was included as an internal
control vector for all transfections. A prokaryotic vector pGEX-3X
was used as a negative control. TNF-a was added to a few wells at
a final concentration of 50 ng/ml at 24 h after transfection as
a positive control for NF-kB activation. Dual-Glo Luciferase Assay
System (Promega) was used to detect luciferase yield in the cells at
4 h after TNF-a addition following the manufacturer’s instruc-
tions. Relative folds of luciferase yields in the samples were
calculated in comparison to a negative control.
Subcellular Fractionation
Nuclear fraction was extracted from normal HeLa and HeLa-
vFLIP stable cells using the CelLytic NuCLEAR Extraction Kit
(Sigma). Cell collection, lysis, and subcellular fractionation were
performed following the manufacturer’s instructions. The nuclear
and cytoplasmic fractions were subjected to Western blot analysis.
Antibodies against b-tubulin and PARP-1 were used to assess the
fractionation efficiency.
Preparation of siRNA and Transfection of BJAB Cells
The siRNA used in this study was designed with siRNA Target
Designer (Version 1.6, Promega) and synthesized with the T7
RiboMAExpressRNAiSystem(Promega).ThesequenceofsiRNA
against RRV ORF71 is 59 GCTGGAGGCCGTGTTTCTC 39.
The efficiency of the siRNA against RRV ORF71 was tested in
HEK293 cells transfected with VenusN1-vFLIP plasmid. Trans-
fection of HEK293 cells with siRNA was accomplished with
CodeBreaker siRNA Transfection Reagent (Promega) as instructed
by the manufacturer. An irrelevant siRNA (59 GAAATTACTG-
CACCTCGCC 39) was used as a negative control. The BJAB cells
were transfected with siRNA by using CodeBreaker siRNA
Transfection Reagent. At 24 h post-transfection, the cells were
harvested or treated for further analysis, as indicated in text.
Statistical Analysis
A single factor pair-wise ANOVA statistical analysis was used to
evaluate the significance in differences between levels of test
parameters in the presence or absence of vFLIP. A two tailed P-
value of less than 0.05 was considered significant.
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